![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiUwXA1ByQWtSEbk8KxCnCsGlj0Kn9KmTXeJSYXFjXTlwbvpQxIx9M8HMfCSPOxGLtpTxn_iCOjfWcGKdyp__m0EzF8Bzuz0iUySzYVP43Jy5iWFg2KH8Y7zQOp4fsm3O1xMtEy1oxuNdag/s320/AKER2021101120211105-752142.png)
Akers Biosciences, Inc. focuses on the development of a vaccine candidate against SARS-CoV-2, a coronavirus causing a pandemic. It has a collaboration agreement with Premas Biotech PVT Ltd. The company was founded in 1989 and is headquartered in Thorofare, New Jersey.
http://www.priceseries.com/trade/AKER-Akers-Biosciences-Inc-stock-gains-21-percent-a-Trade-Record-by-priceSeries-2021101120211105.html
Subscribe by Email
Follow Updates Articles from This Blog via Email
No Comments